Business Wire - Elan Completes Sale of Four Pain Products for Approximately $102 Million
December 2, 2003 -- Business Editors/Health/Medical Writers DUBLIN, Ireland--(BUSINESS WIRE)--Dec. 2, 2003 Elan Corporation, plc (NYSE:ELN) ("Elan") today...
Business Wire - Elan to Sell Four Pain Products for $100 Million
October 22, 2003 -- Business Editors/Health/Medical Writers DUBLIN, Ireland--(BUSINESS WIRE)--Oct. 22, 2003 Elan Corporation, plc (NYSE:ELN) ("Elan") today...
Chemical Market Reporter - OXYCODONE.(Brief Article)
May 22, 2000 -- Purdue Pharma LP has successfully defended its patent position for its sustained-release analgesic product, oxycodone, when the US District Court...
Business Wire - The Following Was Released Today by the Intellectual Property Law Firm of Fish & Neave
May 17, 2000 -- Business/Legal Editors NEW YORK--(BUSINESS WIRE)--May 17, 2000 The following is an announcement by the intellectual property law firm of Fish...
Nurse Practitioner - Contolled-release confusion
May 1, 1999 -- Numerous reports of mix-ups between Purdue Pharma's OxyContin (oxycodone HCl controlled-release tablets) and oxycodone HCI immediate-release tablets...
